Fig. 2.
Kaplan–Meier of drug survival according the calendar year of initiation including overall treatments, ustekinumab interleukin (IL)-17 inhibitors, adalimumab, etanercept and apremilast.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.